Macular Dystrophy
8
1
1
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (8)
High Resolution, High-speed Multimodal Ophthalmic Imaging
Correlation Between OCT and Mf-ERG Findings With BCVA in Patients With Macular Dystrophy
Mechanisms of Inherited Retinal Dystrophies Using Whole Genome Sequencing and in Vitro and in Vivo Models
The Efficacy of Hyperemesis Gravidarum on Macular Thickness, Corneal Thickness and Intraocular Pressure in Pregnancy
Bimodal and Coaxial High Resolution Ophtalmic Imaging
Efficacy of Acupuncture in Macular Diseases
High Resolution Retina Imaging
Saffron Supplementation in Stargardt's Disease